New Zealand markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
37.500.00 (0.00%)
At close: 4:00PM EDT
37.50 0.00 (0.00%)
After hours: 04:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
2,238,532
2,122,353
1,814,254
1,794,894
1,597,930
Operating expenses
Research development
18,637
26,289
83,036
392,609
117,866
Selling general and administrative
188,928
181,715
103,439
61,906
106,440
Total operating expenses
439,662
526,954
-808,922
430,448
658,238
Operating income or loss
1,798,870
1,595,399
2,623,176
1,364,446
939,692
Interest expense
144,127
157,059
268,573
279,956
247,339
Total other income/expenses net
248,441
235,235
84,487
408,924
644,065
Income before tax
1,956,616
1,701,954
2,461,419
1,517,855
1,343,180
Income tax expense
0
0
0
0
0
Income from continuing operations
1,956,616
1,701,954
2,461,419
1,517,855
1,343,180
Net income
971,621
975,040
2,348,535
1,377,729
1,210,025
Net income available to common shareholders
971,621
495,198
1,187,270
1,377,729
1,210,025
Basic EPS
-
1.61
3.35
3.89
3.42
Diluted EPS
-
1.61
3.35
3.89
3.42
Basic average shares
-
607,111
354,176
354,176
354,176
Diluted average shares
-
607,111
354,176
354,176
354,176
EBITDA
-
1,882,071
2,753,916
1,831,078
1,623,786